Vanguard Personalized Indexing Management, LLC Vaxcyte, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $9.45 Billion
- Q3 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 15,855 shares of PCVX stock, worth $661,312. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,855
Previous 12,722
24.63%
Holding current value
$661,312
Previous $413,000
38.26%
% of portfolio
0.01%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding PCVX
# of Institutions
322Shares Held
139MCall Options Held
229KPut Options Held
160K-
Janus Henderson Group PLC London, X014.7MShares$613 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$500 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA12MShares$499 Million8.5% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$415 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6MShares$250 Million0.12% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $2.47B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...